Vaccines
Bionor Pharma is a leading developer of modified peptide-based vaccines targeting rapidly mutating viruses. All sections have been divided into two; one summary and one more comprehensive version.
History
Bionor Pharma's technology can trace it's roots back to 1985 and was spun out as a seperate company in 2000
Platform technology
To read more about the innovative plattform technology that forms the basis of all vaccine candidates
HIV: Vacc-4x Therapeutic vaccine
Here you can read more about the product Vacc-4x and its properties
HIV: Vacc-4x Development
Here you can read more about the clinical development of Vacc-4x
HIV: Vacc-C5
Here you can read more about the humoral HIV vaccine Vacc-C5
Hepatitis C (HCV)
Bionor Pharma is developing a more effective treatment for Hepatitis C
Cervical cancer (HPV)
Bionor Pharma is developing a treatment option for early stage cervical cancer
Influenza
Bionor Pharma is developing a multi-seasonal influenza vaccine
Publications
Here you can find a selection of publications by Bionor Pharma and collaborators
Advisory Boards
The company is supported by independant experts in both technology development and clinical work